Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus

被引:13
|
作者
Costa, Nadia Lago [1 ]
Goncalves, Julie Ane Maria [1 ]
de Lima, Sara Lia Goncalves [1 ]
de Arruda, Jose Alcides Almeida [2 ]
Miranda, Ana Carolina Campos [1 ]
Mesquita, Ricardo Alves [1 ,2 ]
da Silveira, Ericka Janine Dantas [3 ]
Batista, Aline Carvalho [1 ]
机构
[1] Univ Fed Goias, Sch Dent, Dept Stomatol Oral Med & Oral Pathol, Praca Univ S-N,Setor Univ, BR-74605220 Goiania, Go, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil
[3] Univ Fed Rio Grande do Norte, Dept Dent, Postgrad Program Odontol Sci, Natal, RN, Brazil
关键词
immunogenicity; immunohistochemical; lichen planus; mouth diseases; programmed cell death-1 ligand-2 protein; T-lymphocyte receptor; MALIGNANT-TRANSFORMATION; T-CELLS; EVASION MECHANISMS; EXPRESSION; MICROENVIRONMENT; PATHWAY; LESIONS; B7-DC;
D O I
10.1111/odi.13344
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective To investigate the expression of programmed death-ligands 1 and 2 (PD-L1, PD-L2), programmed death-1 (PD-1), CD8 and granzyme B (GrB), as well as its correlation with the severity of oral lichen planus (OLP). Materials and Methods In a collaborative study, 33 cases of OLP were evaluated according to the latest criteria proposed by the American Academy of Oral and Maxillofacial Pathology (AAOMP/2016) and were submitted to immunohistochemistry. Positivity was measured semiquantitatively (PD-L1, PD-L2) and quantitatively (PD-1, CD8, GrB). The severity of OLP was assessed according to clinical subtype, symptomatology and response to corticosteroid therapy. Results Most OLPs were considered to be negative for PD-L1 (66.6%), but high expression of PD-L2 (96.9%) by keratinocytes and immunoinflammatory cells was observed. PD-1(+) cell density/mm(2) was reduced compared to CD8(+) cells. A low cytotoxic immune response (CD8:GrB ratio) was also demonstrated. Interestingly, there were fewer GrB(+) cells in the intraepithelial region in reticular OLP compared to erosive/bullous OLP. Conclusions PD-L1/PD-1 pathways appear to be compromised in OLP due to low PD-L1 expression in most samples. In contrast, PD-L2 overexpression associated with a possible regulation of the cytotoxic immune response suggests an immune tolerance that may contribute to the chronic profile of OLP.
引用
收藏
页码:1246 / 1254
页数:9
相关论文
共 50 条
  • [41] Biomarkers of response to PD-1/PD-L1 inhibition
    Vareki, Saman Maleki
    Garrigos, Carmen
    Duran, Ignacio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 116 : 116 - 124
  • [42] Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer
    Mo, Zhongfu
    Liu, Jing
    Zhang, Qiuyang
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Yang, Shijie
    Li, Huina
    Zhou, Lifei
    You, Zongbing
    ONCOLOGY LETTERS, 2016, 12 (02) : 944 - 950
  • [43] Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry
    Kwiecien, Iwona
    Rutkowska, Elzbieta
    Polubiec-Kownacka, Malgorzata
    Raniszewska, Agata
    Rzepecki, Piotr
    Domagala-Kulawik, Joanna
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (04) : 1679 - 1689
  • [44] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment (vol 121, pg 251, 2015)
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar R.
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2016, 128 (01) : 183 - 183
  • [45] Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
    Kinch, Amelie
    Sundstrom, Christer
    Baecklund, Eva
    Backlin, Carin
    Molin, Daniel
    Enblad, Gunilla
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 376 - 384
  • [46] Association of PD-1, PD-L1 and PD-L2 expression with clinicopathological factors in tongue squamous cell carcinoma
    Tsuchihashi, Kei
    Nakatsugawa, Munehide
    Asanuma, Hiroko
    Miyazaki, Akihiro
    Torigoe, Toshihiko
    CANCER SCIENCE, 2018, 109 : 498 - 498
  • [47] PD-1, CTLA4, PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinoma
    de Vos, Luka
    Dietrich, Joern
    Strieth, Sebastian
    Bootz, Friedrich
    Dietrich, Dimo
    Franzen, Alina
    IMMUNOTHERAPY, 2020, 12 (12) : 903 - 920
  • [48] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Diggs, Laurence P.
    Hsueh, Eddy C.
    BIOMARKER RESEARCH, 2017, 5
  • [49] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Laurence P. Diggs
    Eddy C. Hsueh
    Biomarker Research, 5
  • [50] Evaluation of PD-L1 and PD-1 in Colorectal Polyps
    Mostafa, Mohamed
    Hartley, Christopher
    Mackinnon, Alexander
    Hagen, Catherine
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 : S135 - S135